Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001390478-15-000016
Filing Date
2015-03-10
Accepted
2015-03-10 17:23:01
Documents
4
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A gale-20141231x10kamended.htm 10-K/A 186826
2 EXHIBIT 23.1 gale-20141231xex23110xka.htm EX-23.1 3098
3 EXHIBIT 31.1 gale-20141231xex31110xka.htm EX-31.1 8172
4 EXHIBIT 31.2 gale-20141231xex31210xka.htm EX-31.2 8185
  Complete submission text file 0001390478-15-000016.txt   207609
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33958 | Film No.: 15690146
SIC: 2834 Pharmaceutical Preparations